Celltrion pushes beyond GLP-1 with next-generation obesity drug
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-05-29 15:50 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, South Korea, Drugs, World News
--------------------------------------------------------------------
Snippet:
Korean biopharmaceutical firm targets IND filing next year as it develops first-in-class therapy for obesity, diabetes and metabolic diseases
--------------------------------------------------------------------